Expert interview about cancer vaccines
In this very interesting interview from the Friends of Renal [...]
New cancer vaccine in development
A new vaccine is being heralded as a 'game changer’ [...]
Adjuvant pembrolizumab prolongs overall survival for kidney cancer patients
Surgery (partial or radical nephrectomy) is the standard of care [...]
Immunotherapy combinations versus TKIs for papillary renal cell carcinoma
Papillary renal cell carcinoma (pRCC) is the most common subtype [...]
CAR T cell immunotherapy shows promise for patients with kidney cancer
Chimeric antigen receptor (CAR) T cell therapy is a type [...]
Real world data on the use of cabozantinib plus immunotherapy in the second line
A recent study looked at the use of a combination [...]
Immunotherapy improves survival in kidney cancer patients with brain metastases
A recent real world study has found that giving immunotherapy [...]
Radiotherapy for the management of renal medullary carcinoma
Renal medullary carcinoma (RMC) is a rare and aggressive cancer [...]
NICE approves cabozantinib plus nivolumab for advanced kidney cancer
The National Institute for Health and Care Excellence (NICE) has approved the [...]
PRISM study highlights possibility of reducing dose of immunotherapy
The CheckMate-214 clinical trial was the first study to show [...]
